Rhythm Biosciences Limited (ASX:RHY)
Australia flag Australia · Delayed Price · Currency is AUD
0.0640
0.00 (0.00%)
May 15, 2025, 10:11 AM AEST

Rhythm Biosciences Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2017 - 2019
Net Income
-2.18-6.86-8.22-8.79-6.61-4.02
Upgrade
Depreciation & Amortization
0.190.20.190.10.150.14
Upgrade
Stock-Based Compensation
-1.05-1.0532.610.560.02
Upgrade
Other Operating Activities
-0.65----0.08
Upgrade
Change in Accounts Receivable
-1.03-1.030.91-0.48-0.040.66
Upgrade
Change in Inventory
2.772.77-2.77---
Upgrade
Change in Accounts Payable
----0.510.36
Upgrade
Change in Other Net Operating Assets
-0.16-0.16-0.080.070.040.02
Upgrade
Operating Cash Flow
-2.12-6.14-6.96-6.5-5.4-2.74
Upgrade
Capital Expenditures
-0-0.08-0.1-0.03-0.07-0.05
Upgrade
Investment in Securities
-0.04-----
Upgrade
Investing Cash Flow
-0.56-0.08-0.1-0.03-0.07-0.05
Upgrade
Long-Term Debt Repaid
--0.09-0.09-0.01-0.04-0.14
Upgrade
Net Debt Issued (Repaid)
-0.08-0.09-0.09-0.01-0.04-0.14
Upgrade
Issuance of Common Stock
6.253.023.7412.326.17-
Upgrade
Other Financing Activities
-0.34-0.12-0.02-0.47-0.23-
Upgrade
Financing Cash Flow
5.832.83.6311.855.9-0.14
Upgrade
Net Cash Flow
3.15-3.41-3.435.320.43-2.93
Upgrade
Free Cash Flow
-2.12-6.22-7.06-6.52-5.47-2.79
Upgrade
Free Cash Flow Margin
-66.92%-367.98%-227.94%-268.74%-493.52%-2788.13%
Upgrade
Free Cash Flow Per Share
-0.01-0.03-0.03-0.03-0.03-0.03
Upgrade
Cash Interest Paid
0.0600.01-00.01
Upgrade
Cash Income Tax Paid
--1.69-3.08-2.41-1.11-0.74
Upgrade
Levered Free Cash Flow
-2.23-3.63-4.12-3.28-2.97-1.38
Upgrade
Unlevered Free Cash Flow
-2.19-3.63-4.12-3.28-2.97-1.38
Upgrade
Change in Net Working Capital
0-1.621.940.45-0.53-1.05
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.